Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

 
• By Brenda Sandburg

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.

Opioid Law Concept 3D Illustration
Mallinckrodt reaches agreement in principle with MDL plaintiffs' executive committee to resolve opioid litigation

More from Legal & IP

More from Pink Sheet